AD 01 TP2079
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
FKBPL (FK506-binding protein like)-based peptide. Binds to and upregulates expression of CD44. Inhibits breast cancer stem cell (BCSC) growth. Decreases pluripotency markers and promotes differentiation of BCSCs. Also inhibits endothelial cell migration a
CAS nr:
959961-23-0
Purity:
98%
Molecular Weight:
2703,94
SMILES:
Formula:
C115H187N33O42
Pathway:
Target:
